Clinical trials in cardiovascular medicine

被引:0
作者
Antman, EM [1 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
关键词
drugs; statistics; cost-benefit analysis; trials; myocardial infarction;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E101 / +
页数:4
相关论文
共 50 条
  • [21] In vivo tracking of stem cells for clinical trials in cardiovascular disease
    Frangioni, JV
    Hajjar, RJ
    CIRCULATION, 2004, 110 (21) : 3378 - 3383
  • [22] An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials
    Adeniyi, Oluseyi
    Ramamoorthy, Anuradha
    Schuck, Robert
    Sun, Jielin
    Wilson, Jennifer
    Zineh, Issam
    Pacanowski, Michael
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (04) : 841 - 846
  • [23] New tricks with old dogs: personalised medicine and clinical trials
    Koziol, J. A.
    BRITISH JOURNAL OF CANCER, 2011, 105 (05) : 599 - 601
  • [24] Naturopathic medicine for the prevention of cardiovascular disease: a randomized clinical trial
    Seely, Dugald
    Szczurko, Orest
    Cooley, Kieran
    Fritz, Heidi
    Aberdour, Serenity
    Herrington, Craig
    Herman, Patricia
    Rouchotas, Philip
    Lescheid, David
    Bradley, Ryan
    Gignac, Tara
    Bernhardt, Bob
    Zhou, Qi
    Guyatt, Gordon
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (09) : E409 - E416
  • [25] Core outcome sets for myocardial infarction in clinical trials of traditional Chinese medicine and Western medicine
    Qiu, Ruijin
    Wan, Siqi
    Zhong, Changming
    Han, Songjie
    He, Tianmai
    Huang, Ya
    Wei, Xuxu
    Li, Meng
    Guan, Zhiyue
    Zhang, Xinyi
    Wu, Huanlin
    Shang, Hongcai
    JOURNAL OF EVIDENCE BASED MEDICINE, 2024, 17 (01) : 86 - 94
  • [26] Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials
    Verdecchia, Paolo
    Gentile, Giorgio
    Angeli, Fabio
    Mazzotta, Giovanni
    Mancia, Giuseppe
    Reboldi, Gianpaolo
    JOURNAL OF HYPERTENSION, 2010, 28 (07) : 1356 - 1365
  • [27] A systematic review of subgroup analyses in randomised clinical trials in cardiovascular disease
    Brand, Korbinian J.
    Hapfelmeier, Alexander
    Haller, Bernhard
    CLINICAL TRIALS, 2021, 18 (03) : 351 - 360
  • [28] Event Rates in Randomized Clinical Trials Evaluating Cardiovascular Interventions and Devices
    Mahmoud, Karim D.
    Lennon, Ryan J.
    Holmes, David R., Jr.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (03) : 355 - 363
  • [29] Is the Evidence From Clinical Trials for Cardiovascular Risk or Harm for Glitazones Convincing?
    Mannucci, Edoardo
    Monami, Matteo
    CURRENT DIABETES REPORTS, 2009, 9 (05) : 342 - 347
  • [30] Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice
    Avogaro, Angelo
    Fadini, Gian Paolo
    Sesti, Giorgio
    Bonora, Enzo
    Del Prato, Stefano
    CARDIOVASCULAR DIABETOLOGY, 2016, 15